Abstract | BACKGROUND: METHODS: Twenty-four children, aged 3-6 years, with autism according to the DSM IV criteria and using CARS were included in the study. Concentrations of CoQ10-TOTAL, γ- and α- tocopherol, β- carotene, and lipid peroxidation were determined in plasma before and after three months of supportive therapy with ubiquinol at a daily dose 2 × 50 mg. Data on behavior of the children were collected from parents at the same time. RESULTS:
Ubiquinol supportive therapy improved symptoms in children with autism, as communication with parents (in 12%), verbal communication (in 21%), playing games of children (in 42%), sleeping (in 34%), and food rejection (in 17%), with CoQ10-TOTAL plasma level above 2.5 μmol/L. CONCLUSIONS: Beneficial effect of ubiquinol in children with autism has been demonstrated for the first time. We assume that plasma concentration of CoQ10-TOTAL and lipid peroxidation could be used as relevant biomarkers of ubiquinol supportive therapy.
|
Authors | Anna Gvozdjáková, Jarmila Kucharská, Daniela Ostatníková, Katarína Babinská, Dalibor Nakládal, Fred L Crane |
Journal | Oxidative medicine and cellular longevity
(Oxid Med Cell Longev)
Vol. 2014
Pg. 798957
( 2014)
ISSN: 1942-0994 [Electronic] United States |
PMID | 24707344
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antioxidants
- Thiobarbituric Acid Reactive Substances
- Ubiquinone
- ubiquinol
|
Topics |
- Antioxidants
(metabolism)
- Autistic Disorder
(blood, drug therapy, psychology)
- Behavior
- Binding Sites
- Child
- Child, Preschool
- Female
- Humans
- Male
- Thiobarbituric Acid Reactive Substances
(metabolism)
- Ubiquinone
(analogs & derivatives, metabolism, therapeutic use)
|